Equally crucial is the correction of potassium imbalance, which should be initiated prior to insulin therapy if serum potassium is below 3.3 mmol/L, to prevent life-threatening cardiac arrhythmias. This evidence concerns the gene INS and chronic obstructive pulmonary disease.